Cefoxitin EP Impurity A

Compatible stability of injected cefoxitin sodium and dexamethasone
By Xie, Yan-qing
From Hainan Yixueyuan Xuebao (2015), 21(10), 1316-1317, 1321
 
Study of a major impurity in cefoxitin sodium
By Li, Zhe-yu; Wang, Yu-chi; Zhang, Jing-xia; Zhang, Chun-ran; Xu, Ming-qin; Li, Qiang; Deng, Jun-feng; Tang, Ke-hui
From Zhongguo Kangshengsu Zazhi (2015), 40(12), 925-929
 
Compatible stability of cefoxitin sodium for injection and sodium potassium magnesium calcium and glucose injection
By Yang, Jing; Liu, Zi-ling; Yang, Jian; Li, Jun-yi; Zhang, Xin-yu; Song, He-di; Zhang, Ting-hui
From Zhongguo Yaofang (2014), 25(34), 3217-3218
 

Cefoxitin EP Impurity A is chemically Cyclohexanaminium (6R,7S)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP). It is also known as Decarbamoylcefoxitin (EP). Cefoxitin EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Cefoxitin EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefoxitin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.